Impel Pharmaceuticals Inc

Impel Pharmaceuticals Inc. is a commercial stage pharmaceutical company focused on developing and providing transformative therapies that unlock the full potential of therapeutic molecules for people suffering from diseases with high unmet medical needs, with an initial focus on the central nervous system.

Impel Pharmaceuticals has developed a proprietary drug delivery technology system that targets the vascular-rich, upper nasal space,1 with multiple clinical trials suggesting rapid absorption and consistent drug bioavailability with ease of use in mind for a patient, provider, or caregiver.
Impel Pharmaceuticals performance Precision Olfactory Delivery (POD®) technology has the potential to lead to injection-like bioavailability, which may improve clinical outcomes non-invasively.